Reuters logo
BRIEF-A1M Pharma able to finalize application to initiate clinical studies
November 14, 2017 / 7:50 AM / a month ago

BRIEF-A1M Pharma able to finalize application to initiate clinical studies

Nov 14 (Reuters) - A1M PHARMA AB:

* A1M PHARMA REPORTS POSITIVE RESULTS FROM ITS GLP TOXICOLOGY STUDY - NOW ABLE TO FINALIZE APPLICATION TO INITIATE CLINICAL STUDIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below